CoRegen Stock
CoRegen is a biopharmaceutical company leveraging its proprietary gene regulatory platform to engineer immune cells for novel cancer therapies. It programs regulatory T cells by targeting master gene regulators, enabling them to infiltrate tumors and activate immune responses while mitigating toxicity. The platform advances new adoptive cell therapies for challenging cancers by combining gene editing with immune system modulation.
Sign up for SecondMarket® to view the market and buy or sell CoRegen Stock
Buy + SellCoRegen Funding
Sign up to gain insights into CoRegen funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series B | May 08, 2025 | 62.64M | ||
| Series A | Feb 03, 2025 | 7.50M | ||
| Series A | Feb 03, 2025 | 2.50M | ||
| Series A | Jan 19, 2025 | 20.75M | ||
| Series A | Feb 08, 2024 | 14.50M |
See CoRegen Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into CoRegen Stock Valuation + Share Prices
View real-time Tape D® data on CoRegen stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
CoRegen Management Team
-
Board Member
Bert W. O'Malley
-
Board Member
Edward Benz, Jr.
-
Board Member
Jonathan W. Simons
-
Board Member
Lee Fleisher
-
Board Member
Suneet Varma
-
Board Member
William A. Haseltine
-
CFO
John Thomas, Jr.
-
Chief Science Officer
David Lonard
-
President, Board Member
Steve Gorlin
Learn More About CoRegen Stock
Buy CoRegen Stock
01CoRegen stock does not trade on public stock exchanges. CoRegen stock is considered a private security and you need to be an accredited investor to trade shares. To invest in CoRegen stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell CoRegen Stock
02CoRegen Stock does not trade on public stock exchanges. In order to sell CoRegen shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
CoRegen Stock Price
03CoRegen does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view CoRegen share price and other valuable private market data.
Read more about secondary market private company stock prices:
CoRegen Stock Ticker Symbol
04There is no ticker symbol for CoRegen stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell CoRegen Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell CoRegen stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in CoRegen Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in CoRegen stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
CoRegen Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
CoRegen IPO
08CoRegen is a private company and has not had an IPO. There is currently no CoRegen IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to CoRegen IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell CoRegen Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
